ALEXION PHARMACEUTICALS INC·4

Feb 5, 7:57 PM ET

ALEXION PHARMACEUTICALS INC 4

4 · ALEXION PHARMACEUTICALS INC · Filed Feb 5, 2014

Insider Transaction Report

Form 4
Period: 2014-02-03
MATHIS LARRY
Director
Transactions
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-0330,0000 total
    Exercise: $18.08From: 2008-08-09Exp: 2018-05-09Common Stock, par value $.0001 per share (30,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$96.35/sh+1,712$164,95131,168 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$88.40/sh+3,237$286,15134,405 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$49.43/sh+5,572$275,42439,977 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$26.64/sh+7,932$211,30847,909 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$18.01/sh+30,000$540,30090,185 total
  • Sale

    Common Stock, par value $.0001 per share

    2014-02-03$155.23/sh15,020$2,331,55595,165 total
  • Sale

    Common Stock, par value $.0001 per share

    2014-02-03$159.01/sh13,501$2,146,79429,456 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-031,7121,713 total
    Exercise: $96.35From: 2013-08-07Exp: 2023-05-07Common Stock, par value $.0001 per share (1,712 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-035,5720 total
    Exercise: $49.43From: 2011-08-11Exp: 2021-05-11Common Stock, par value $.0001 per share (5,572 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-037,9320 total
    Exercise: $26.64From: 2010-08-12Exp: 2020-05-12Common Stock, par value $.0001 per share (7,932 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-0312,2760 total
    Exercise: $16.83From: 2009-08-13Exp: 2019-05-13Common Stock, par value $.0001 per share (12,276 underlying)
  • Sale

    Common Stock, par value $.0001 per share

    2014-02-03$158.41/sh30,222$4,787,46742,957 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$16.83/sh+12,276$206,60560,185 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2014-02-03$10.84/sh+20,000$216,800110,185 total
  • Sale

    Common Stock, par value $.0001 per share

    2014-02-03$156.24/sh9,664$1,509,90385,501 total
  • Sale

    Common Stock, par value $.0001 per share

    2014-02-03$157.35/sh12,322$1,938,86773,179 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-033,2370 total
    Exercise: $88.40From: 2012-08-08Exp: 2022-05-08Common Stock, par value $.0001 per share (3,237 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2014-02-0320,00010,000 total
    Exercise: $10.84From: 2007-08-03Exp: 2017-05-03Common Stock, par value $.0001 per share (20,000 underlying)
Footnotes (5)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $155.00 - $155.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $156.00 - $156.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $157.00 - $157.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $158.00 - $158.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.00 - $159.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_139164825449593.xmlPrimary

    FORM 4